Investigation Overview
August 27, 2013 (Shareholders Foundation) - An investigation on behalf of investors who currently hold shares of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX), was announced concerning whether the takeover of Onyx Pharmaceuticals, Inc. by Amgen for $125 per NASDAQ:ONXX share is unfair to NASDAQ:ONXX stockholders. The investigation by a law firm concerns whether a potential takeover would ...
You must register (for free) or login to view the entire investigation.